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Kuwait in the different billiary interventional procedures used for management of billiary diseases.
Patients and methods: The study was conducted from March 2007 until September 2009 on 64
patients suffering from obstructive jaundice and/or billiary diseases due to different causes.
Results: According to the patient’s diagnosis and the interventional procedure applied, our patients
were classiﬁed into four groups: (I) patients with malignant obstructive jaundice who had decom-
pression of the obstructed billiary tree; encountered in 44 patients (68.75%). (II) Patients with
benign billiary strictures encountered in 9 patients (14.06%), where successful balloon dilatation
was encountered in 6 patients (9.37%). (III) Patients with bile duct stones who had stone removal;
encountered in 8 patients (12.5%), with successful stones elimination in all of the 8 patients. (IV)
Patients with bile leak due to bile duct defect and leakage who had billiary stenting till sealing of
the bile leak; encountered in 3 patients (4.68%). Technical and clinical success rate in this patient
series was high and comparable with the results of the others.5010730.
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Over the past two decades, numerous studies (1–3) have docu-
mented that surgery for severe obstructive jaundice is associ-
ated with a post-operative mortality of 15–25% and
morbidity of 40–60%.
Because of the signiﬁcant risks associated with an operation
for billiary tract obstruction, percutaneous transhepatic inter-
ventional billiary procedures have achieved widespread appli-
cation primarily as a mean of non-operative billiary
decompression for benign and malignant bile duct strictures.
Moreover, it may eliminate the need for further surgical man-
agement or allow time for the patients’ condition to improve
before subsequent deﬁnitive surgery (4).
Also percutaneous billiary drainage is used as a non-
operative management for patients with sever bile duct injuries
associated with extravasation of bile into the peritoneal cavity
or billiary-cutaneous ﬁstulas, and may lead to healing of the
ﬁstula making additional billiary surgery unnecessary (5).
Percutaneous removal of billiary stones is another interven-
tional billiary technique, which can be a viable alterative pro-
cedure in the management of bile duct lithiasis by mean of
percutaneous antegrade evacuation of bile duct stones with
dilatation of the papilla using an angioplasty catheter and as-
sisted with an occlusion balloon to expel the calculi in cost-
effective, non-traumatic, and safe procedure that retains the
anatomic and functional integrity of the sphincter (6).
Therefore, this study was undertaken to report our experi-
ence and results in Al-Amiri Hospital-Kuwait, as regard the
different interventional techniques used as a non-surgical ther-
apeutic options for the management of different billiary dis-
eases and to highlights the indications, techniques, outcome
and complications of these different billiary interventional
procedures.
2. Patients and methods
The study was conducted from March 2007 till September
2009 on 64 patients suffering from obstructive jaundice and/
or billiary disease due to different causes. They were 35 male
(54.68%) and 29 female (45.31%). Their ages ranged from
26 to 68 years with a mean age of 47 years.
The patient’s complaints were jaundice in 60 patients
(93.75%), weight loss in 18 patients (28.12%), pruritis in 11
patients (17.18%), indigestion, nausea and vomiting in 9 pa-
tients (14.06%), pain in 8 patients (12.5%), and fever in 3 pa-
tients (4.68%).
All patients were subjected to the following:
1. Pre-procedure full laboratory investigations including:
A. Total bilirubin, liver function tests, serum creatinine,
WBCs, and hemoglobin, in order to establish a pre-
procedure base line to assess later progress or post-pro-
cedure complications such as sepsis or bleeding.B. Evaluation of coagulation status including Platelet
count and Prothrombin time. The examination was
only performed if INR was <1.4.2. Review of the radiological investigations, e.g., ultrasonog-
raphy, CT, MRI, MRCP and/or PTC.
3. Based on the patient’s diagnosis and the image guidance,
the required interventional procedure, its approach and
technique of billiary access was decided. It depended upon
whether there was billiary obstruction, the cause of obstruc-
tion, and its level in the billiary tree; whether high or low
obstruction.
The procedure was performed under sonographic and/or
ﬂuoroscopic guidance, with the patient under local anesthesia
and conscious sedation. Prophylactic IV antibiotics (gentami-
cin 5 mg/kg/24 h, ampicillin 2 g/24 h, and metronidazole 1 g/
24 h) were routinely administrated 12 h before the procedure
and for 48–72 h afterwards.
Ultrasonographic examination was done to choose a
peripherally dilated duct to be punctured. A right intercostal
and/or left epigastric (sub-xiphoid) approach was chosen. A
22-G needle was used for puncture of the chosen bile duct.
After the inner stylet was withdrawn, contrast medium was in-
jected gently while the needle is retracted under ﬂuoroscopic
guidance. When the 22-G needle was in the bile duct, a 7
French coaxial set was passed over a 0.018-in. guide wire,
and its inner two components (wire and inner coaxial dilator)
were removed and cholangiography was done through the
sheath of the coaxial system to delineate the billiary tree.
In a dilated billiary system, the bile was allowed to drain
before contrast injection to decrease the risk of inducing cho-
langitis and sepsis because of over-distension of the obstructed
billiary tree.
After gaining access to the billiary tree and the cholangio-
gram was performed, one of the following billiary interven-
tional procedures was resorted to according to the plan of
management.
2.1. Billiary decompression and drainage
It was done through one of the following techniques:
2.1.1. External billiary drainage
A malleable hydrophilic guide wire (0.035 in.) was negotiated
as far as possible into the CBD. The sheath of the coaxial sys-
tem was then withdrawn. Changing the wire, a stiff wire over a
cobra catheter and using dilators of increasing diameters were
used, till reaching the size of the drainage catheter. Then, a
(Flexima pigtail drainage catheter, 8 French) 30 cm, was intro-
duced with its tip in the CBD proximal to the stricture and
contrast medium was injected into the catheter to conﬁrm its
proper position. The free end of the catheter was then con-
nected to a bag to collect the bile and the catheter was ﬁxed
to the skin by a stitch.
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The malleable guide wire was manipulated to pass through the
stricture and get into the duodenum. A manipulation catheter
was introduced and a stiff wire was introduced instead of the
malleable wire. Dilators were then used until reaching the re-
quired tract dilatation. (Ring-Lunderquist internal–external
drainage catheter, 8.3 French) 50 cm, was then introduced with
the proximal holes proximal to the stricture and loop was posi-
tioned in the duodenum just below the ampulla to prevent the
catheter from being pulled out.
2.1.3. Percutaneous plastic stent
The same procedure was done as in internal–external drainage
till dilatation of the tract and stricture to the required size of
the stent (Carey Coons stents, 10 and 12 French) 15 and
20 cm, were used. The stent was then introduced on its intro-
ducer, pushed by the pusher, and positioned in place where its
distal end was distal to the papilla within the duodenum and
its proximal end within the billiary tree. Contrast was then in-
jected to ensure correct position, which could be adjusted
using the threads attached to the proximal end of the
catheter.
2.1.4. Percutaneous metallic stent
The same procedure was done as in internal–external drainage
and then the Wallstent was introduced through the sheath
while constrained on the delivery catheter using a delivery sys-
tem of 7 French and placed so that the distal marker was pro-
jected through the papilla into the duodenum, while proximal
marker was above the upper end of the stricture. The stent was
then deployed by withdrawal of the outer membrane of the
catheter. When position was acceptable, the outer membrane
was withdrawn all the way (position could still be adjusted
as long as the outer membrane is withdrawn only to the middle
marker) and contrast medium injected through the outer mem-
brane to check the position of the stent.
2.1.5. Combined percutaneous and endoscopic billiary stent
This was done in two stages. The ﬁrst stage was to insert an
internal/external drain as mentioned above. Then the com-
bined procedure was done later with the combined work of
the radiologist and endoscopist, during which a long guide
wire was advanced through the internal/external catheter into
the duodenum. The catheter was then removed and a Dormia
basket was then introduced through the endoscope to grab the
wire projecting through the papilla and the plastic stent was
then applied over the guide wire through the endoscope.
2.2. Balloon dilatation of benign stricture
Having gained access into the billiary system, 1–3 days waiting
period was usually required prior to initiation of balloon dila-
tation. After that a stiff guidewire was introduced through the
draining catheter, advanced, and manipulated to pass the
point of stricture. The billiary drainage catheter was removed
and an angioplastic balloon was advanced over the guidewire
under ﬂuoroscopic guidance to the stricture site. The diameter
of the balloon used depends upon the size of the duct and nar-
row segment; however, usually we started with an 8–10 mm
diameter balloon. If there was no waist seen during balloon
inﬂation at the site of billiary stricture, a balloon with larger
diameter was used and the dilatation repeated.After satisfactory dilatation of the stricture was achieved,
the stricture was stented with a large internal/external billiary
drainage catheter for several months (6–12 months).
2.3. Stone removal
Stone removal from the bile ducts was achieved through
sphincteroplasty and occlusion balloon for clearance of the
bile duct calculi.
The same protocol for access of the billiary tree was fol-
lowed as mentioned above in all patients; unless the patient
had ‘‘T’’ tube inserted post-operatively where the maneuver
was done through it.
We started the procedure by replacing the drainage catheter
with super-stiff 0.035-in. guidewire, with its tip in the duode-
num. This was followed by introduction of a vascular intro-
ducer of 8–10 French caliber with its tip in the bile duct.
Through the introducer, cholangiogram was performed to as-
sess the number and location of the stones and the status of the
papilla.
A standard 10- or 12-mm angioplasty balloon; 6 cm in
length was then inserted over the guidewire and positioned
symmetrically across the papilla. The balloon was then inﬂated
until the waist disappeared. This pressure can be up to 12–
14 atm, with average of 6 atm being usually used. Inﬂation
was usually maintained for 30–60 s, and sometime was needed
to be repeated. The balloon diameter varied between 6 and
23 mm (mean 12 mm), to be equal or slightly greater than’
the minimum diameter of the largest calculus. After dilating
the papilla, the balloon was removed carefully to avoid pulling
the stones proximally into the intrahepatic tree. The balloon
was replaced by a Fogarty-type 11.5 mm occlusion balloon,
which is inﬂated proximal to the stones and slided along the
guidewire, pushing the stones towards the duodenum through
the dilated papilla.
After the stones were eliminated, the introducer was
exchanged for an 8-French pigtail catheter to be placed in
the common bile duct proximal to the papilla and kept for
external drainage and the ﬁnal cholangiography was done
through it 2–3 days later.
In case of large stones that are more than 15 mm in diam-
eter, we used Dormia basket to fragment the stones before
pushing them into the duodenum.
If the tract of the billiary drainage showed pronounced
bends, a hydrophilic angled guidewire of 0.035 in. was passed
through the drainage catheter into the duodenum. We then
replaced the drainage catheter with a multipurpose angled
catheter, which was turned and pulled to straighten the
pathway.
2.4. Bile diversion for bile leak
After gaining an access to the billiary system, (which was not
dilated in theses cases); an 8.3 French multiple side holes poly-
ethylene pigtail catheter was placed with its tip in the duode-
num and the side holes on both sides of the site of
extravasation from the bile duct. External billiary drainage
was used initially until signiﬁcant reduction of the amount of
billiary extravasation was seen in the repeated cholangiograms.
Then internal billiary drainage into the duodenum was used.
The patients were discharged after changing the 8.3 French
catheters with larger one. The catheters were then changed
462 A. Galal et al.every 2 months. The catheters were removed 2–7 months,
when follow up cholangiograms revealed persistently normal
appearing ducts without extravasation, strictures or calculi.
After the procedure
– After any of the above-mentioned procedures, vital signs
including heart rate, temperature, breathing, and blood
pressure were checked frequently. Several doses of IV
antibiotic were given to prevent infection.
– Serum total bilirubin was performed on the 7th and 14th
day.
– Ultrasound examination was performed in the few days
following the procedure.
3. Results
According to the patient’s diagnosis and the interventional
procedures applied, our patients were classiﬁed into four
groups: (Table 1).
1. Patients with malignant obstructive jaundice (malignant
stricture) who had decompression of the obstructed billiary
tree; encountered in 44 patients (68.75%).
2. Patients with benign billiary strictures encountered in 9
patients (14.06%). Balloon dilatation of the billiary stric-
ture was applied in 8 patients (12.5%), and was successful
in 6 patients (9.37%). External drainage was done for the
remaining 1 patient (1.56%) who had tight stricture and
could not be crossed.
3. Patients with bile duct stones that had stone removal;
encountered in 8 patients (12.5%).
4. Three patients (4.68%) with bile leak due to bile duct defect
had billiary stenting.
3.1. Group I
According to our classiﬁcation, all the 44 patients (68.75%) in
this group had obstructive jaundice due to malignant causes.
These included cholangiocarcinoma in 15 patients (23.43%),
cancer head of the pancreas in 11 patients (17.18%), periam-
pullary carcinoma in 8 patients (12.5%), liver metastasis in
six cases (9.37%), porta-hepatis lymph nodes in 3 patients
(4.68%), and hepatocellular carcinoma (HCC) in 1 patient
(1.56%).
All patients were documented pathologically either by per-
cutaneous or endoscopic biopsies, except for 3 patients
(4.68%) diagnosed as having cholangiocarcinoma where the
diagnosis was based on their radiologic appearances.Table 1 The encountered billiary diseases in the 64 patients
included in the study.
Group No of cases %
Malignant stricture 44 68.75
Benign stricture 9 14.06
Stone removal 8 12.5
Bile leak 3 4.68
Total 64 100Billiary drainage was done for all of these 44 patients
(68.75%). The approach and technique of drainage depended
upon the cause of obstruction and its level in the billiary tree;
whether high or low obstruction, where we followed the algo-
rithm published by Covey and Brown (7).
The right approach (Fig. 1) was used in 32 patient (50%),
the left approach in four cases (6.25%) and bilateral approach
(Fig. 2) in eight cases (12.5%).
Billiary access was achieved in all the 44 patients. The
malignant billiary stricture was successfully crossed in 34 pa-
tients (53.12%), and was not crossed in 6 patients (9.37%).
Two (3.12%) of those latter patients had periampullary carci-
noma, two (3.12%) had hilar cholangiocarcinoma, one
(1.56%) had hilar lymphadenopathy, and one (1.56%) had
cancer head of the pancreas, where external billiary drainage
was resorted to in those 6 patients (9.37%).
In the remaining 4 patients (6.25%) isolated segments of
billiary obstruction was encountered where the stricture was
successfully passed from one side by internal–external catheter,
but not from the other side, and external billiary drainage was
done from that side (Fig. 2) in 3 patients (4.68%) to relieve the
hyperbilirubinaemia, while in the remaining patient (1.56%)
there was no need for external drainage from the other side be-
cause of the satisfactory reduction of the bilirubin level that
was achieved.
Metallic billiary stents were deployed in 24 patients (37.5%)
with malignant billiary obstruction (Fig. 3), with correct posi-
tioning and patency of the stent was achieved in all of them.
Among those 24 patients (37.5%) with metallic stents, we
used two stents in the same patients in eight cases (12.5%);
of them ‘‘7’’ conﬁguration billiary stents (Fig. 4b) were used
in 2 patients (3.12%) with klatskin tumor, while trident stents
(Fig. 4c) in multiple isolated segments were used in 2 patients
(3.12%).
Plastic stents were inserted in 10 patients (15.62%) with
malignant stricture. Six of them (9.37%) as a pre-operative step,
while the remaining 4 patients (6.25%) had short life expec-
tancy. In 2 patients (3.12%) of them with periampullary
carcinoma, combined PTBD and ERCP technique with implan-
tation of an endoscopic plastic stents was done (Table 2).Fig. 1 Internal external billiary drainage catheter through the
right side crossing low billiary obstruction into the duodenum in a
case of pancreatic carcinoma.
Fig. 2 (a) PTC shows isolated segment of right bile duct in a case of Klatskin tumor involving the conﬂuence of the hepatic ducts and
extending into the common hepatic duct, (b) internal–external billiary drainage was inserted from the right side, still the
hyperbilirubinaemia did not resolve, (c) second puncture for left lobe of the liver with insertion of external drainage because the lesion
could not be crossed from left side.
Fig. 3 (a) PTC shows malignant stricture (cholangiocarcinoma)
of the CBD. (b) Self-expanding metallic stent (Wallstent) crossing
through the malignant stricture with satisfactory drainage of the
of the billiary tree through the stent.
Interventional radiology in billiary diseases: A non-surgical therapeutic option 4633.1.1. Follow up
The mean observation time of the patients was about 6 months
(range 1–12 months).
At the end of 6 month observation period, 12 patients
(18.75%) died from tumor progression, and multi-organ fail-
ure. Another 3 patients (4.68%) had stent occlusion with
recurrent jaundice.
One (1.56%) of theses patients had a single plastic stent and
the other 2 patients (3.12%) had bilateral metallic stents. The
occluded plastic stent occurred after 4 months and was left
with no further management as the patient was already in a
terminal stage. The occluded metallic stents occurred after
6 months where ultrasound examination showed soft tissue
echogenicity within the stents due to tumor growth and had
two endoscopic plastic stents inserted by their side via com-
bined percutaneous and endoscopic technique.3.2. Group II
Nine patients (14.06%) with benign strictures were included in
our study. Of them, 6 patients (9.37%) were due to post-lapa-
roscopic cholecystectomy, and 2 patients (3.12%) were due to
strictures at the anastomotic site of choledochojejunostomy,
while the remaining patient (1.56%) was due to sclerosing
cholangitis.
Billiary access was achieved in all the 9 patients. Of them, 1
patient (1.56%) had tight stricture and could not be crossed,
where external billiary drainage was done for him followed
by surgical bypass.
The patient (1.56%) with sclerosing cholangitis had multi-
ple strictures and PTD was not applicable even after endo-
scopic stenting and repeated trials of dilatation.
Repeated balloon dilatation was done for the remaining 7
patients (10.93%) of post-operative strictures with long-term
insertion of internal–external catheter up to 9 months
(Fig. 5). Follow up for 6 months after successful completion
of the clinical trial was achieved (no elevation in the liver func-
tion tests, bilirubin, episodes of cholangitis, etc.).
Six (9.37%) out of these 7 patients (10.93%) were success-
fully dilated, while recurrent stricture was met in 1 patient
(1.56%) with post-cholecystectomy stricture and was operated
by choledochojejunostomy.
3.3. Group III
These include 8 patients (12.5%) with bile duct stones. Three
patients (4.68%) of them had previous laparoscopic cholecys-
tectomy from variable durations. One patient (1.56%) had sus-
pected retained CBD stones after recent cholecystectomy by
open surgery. Other 2 patients (3.12%) had accidental discov-
ery of CBD stones during PTC, 1 patient (1.56%) was referred
to drain cholangitis and sepsis and the remaining patient
(1.56%) to investigate jaundice of unknown origin.
The average diameter of the stones ranged from 4 to
20 mm. They were multiple in 5 patients (7.81%) and single
in 3 patients (4.68%). Six patients (9.37%) had complete
Table 2 PTBD procedures among 44 patients with malignant
strictures.
PTBD procedure No. of cases
Metallic stent 24
Plastic stent 10
External drain 6
Combined internal external drain and external drain 3
Internal external drain 1
Total 44
Fig. 4 Different conﬁgurations of metallic stents. (a) Klatskin tumor with isolated billiary segments. (b) ‘‘7’’ conﬁguration billiary stents
for the same patient, extending from the right to the left bile duct and from the left duct into the common bile duct. (c) Trident metal stents
in multiple isolated billiary segments (arrows).
464 A. Galal et al.technical success in one attempt, while 2 patients (3.12%) had
more than one attempt. These latter 2 patients (3.12%) had
large CBD stones (larger than 15 mm in diameter) where frag-
mentation of the stones by Dormia basket before expelling
them into the duodenum was done (Fig. 6).
All the patients has percutaneous access to the billiary tree,
except for the patient with open cholecystectomy who had ‘‘T’’
tube inserted post-operatively and the procedure was done
through it.Fig. 5 (a) Cholangiogram shows benign stricture at the anastomo
stricture. (c) Stent inserted crossing the stricture site.All patients were discharged within 2–7 days after conﬁrm-
ing the complete clearance of the bile duct from stones by chol-
angiogram, except for the patient with open cholecystectomy
who was discharged after 2 weeks.
3.4. Group IV
Three patients (4.68%) had bile leak after laparoscopic chole-
cystectomy and the post-operative cholangiograms revealed
extravasation from defects in the common bile duct in 2 pa-
tients (3.12%) and from the common hepatic duct in the
remaining patient (1.56%). This extravasation was into the
peritoneal cavity in 2 patients (3.12%) and into a localized
biloma in the third patient (1.56%), where percutaneous drain-
age of the biloma was done under sonographic guidance.
Surgery for the billiary tract was not required in those 3
patients (4.68%), because billiary leaks stopped after percuta-
neous billiary drainage and on subsequent catheter cholangio-
grams, billiary leaks were completely sealed within 10 days to
2 months (mean 35 days) of drainage (Fig. 7). The catheters
were removed 2–7 months (mean 4.5 months), when followtic site of choledochojejunostomy. (b) Balloon dilatation of the
Fig. 6 Stone removal. (a) Cholangiogram shows retained large stone in the CBD after cholecystectomy. (b) Occlusive balloon (white
arrow) inﬂated with air above the fragmented calculus, pushing it through the papilla. (c) Follow up cholangiogram shows complete
clearance of the bile duct calculi.
Fig. 7 Bile leak (a) Billiary leak across a rent in the CBD. (b)
One month later follow up after internal stent insertion; the leak
was stopped.
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ducts without extravasation, stricture or calculi.
3.4.1. Complications
Five patients (7.81%) had hemobilia as a complication of the
billiary interventional techniques in the current study. Two
of them (3.12%) had the hemobilia draining from the liver
tract after insertion of a percutaneous plastic stents. An exter-
nal drain was left in situ and was clamped for 3 days, after
which it was unclamped, the hemobilia was resolved and check
cholangiogram was performed to ensure the patency of the
stent and decompression of the billiary system.
One patient (1.56%) had mild hemobilia (of venous origin)
during stone removal and was resolved with cold saline lavage.
One patient (1.56%) had latent bleeding around the cathe-
ter developed 2 weeks following billiary drainage. The patient
was investigated with hepatic angiogram, which revealed blood
extravasation through the right hepatic artery branch adjacentto the draining catheter (Fig. 8) and was successfully embol-
ized with stainless steel coil.
The remaining patient (1.56%) had metastatic liver disease
and experienced hemobilia several days after billiary drainage
from the left side. His cholangiogram revealed portal vein bill-
iary ﬁstula (Fig. 9) presumably because the left billiary drain-
age catheter passed through left portal vein before eventually
passed to the left bile duct. Right sided billiary drainage was
done before removal of the left billiary drainage catheter and
left portal vein embolization with large coil was done.
Three patients (4.68%) were complicated with cholangitis
and developed sepsis. They were managed conservatively with
IV antibiotics and supportive therapy.
Two patients (3.12%) had billiary leak. One (1.56%) of
them had malignant billiary obstruction and had an internal/
external drain inserted. The patient had percutaneous drainage
of the intra-abdominal bile leak and the abdominal drain was
removed 1 week after resolution of the billiary leak. The sec-
ond patient (1.56%) had mild billiary leak after post-cholecys-
tectomy stricture dilatation and an external drain was inserted.
The symptoms including abdominal pain and distension were
resolved after 36 h of antibiotic administration and supportive
therapy.
One patient (1.56%) with CBD cholangiocarcinoma pre-
sented few days after metallic stent insertion with generalized
rigidity and rebound and was diagnosed as billiary peritonitis.
He was treated conservatively and symptoms resolved after
48 h.
4. Discussion
The last few years have seen major developments in the man-
agement of billiary-related diseases. In addition, new imaging
techniques offer the opportunity to accurately visualize the
billiary system without instrumentation of the ducts. As a con-
sequence, clinicians are now faced with a number of potentially
valid options for managing patients with billiary diseases using
safe and effective minimally invasive procedures with positive
and short-term outcomes (8).
Since its introduction, PTD has provided a reasonable
alternative to operative decompression for relief of bile duct
obstruction due to either benign or malignant diseases (9). It
Fig. 9 Left portal vein billiary ﬁstula experienced as hemobilia from a left sided billiary drainage as the draining catheter passed through
the left portal vein before eventually passed to the left bile duct; injuring the left portal vein. (a) Portal venography revealed extravasation
of the blood into the billiary drainage catheter. (b) Transhepatic catheter into the portal venous system extending into the left portal vein
with embolization with large coil (arrow) after removal of the left billiary drainage catheter and replacement by right sided drainage
catheter. (c) Venogram revealed completely occluded left portal vein with no extravasation of the blood.
Fig. 8 Right hepatic artery extravasation: presented by hemobilia from the right side 2 weeks after bilateral billiary drainage. (a) Hepatic
artery angiogram revealed extravasation into the drainage site. (b) Micro-catheter is passed to the bleeding site with coil embolization. (c)
Repeated angiogram revealed no further extravasation into the billiary drainage tract.
466 A. Galal et al.has been also increasingly used for removal of bile duct stones
and drainage of bile leaks and ﬁstulas (5,8).
Having known this; we are going to discus our experience in
the different interventional billiary techniques and outline their
advantage, and compare our results with the published
literatures.
4.1. Malignant billiary obstruction
Percutaneous transhepatic stent insertion is an established pal-
liative modality to relieve malignant billiary obstruction with
satisfactory billiary decompression and symptom relief in 88–
96% of cases. It has a distinct advantage over ERCP in cases
of high billiary obstruction, as well as one or more appropriate
segments for drainage can be chosen with the help of ultra-
sound guidance (10).
Metallic stents have been found to be superior to plastic
stents in palliative decompression of cases of non-operable
malignant obstructive jaundice (11). This is because they aredelivered through a small caliber sheath that is only 7 French
or over small caliber catheter in a contracted state and when
released across the obstructing lesion they expand to a large
internal diameter; up to 30 French. Thus they combine the
advantage of a small track through the liver and a large lumen,
which is less likely to become occluded by encrusted bile like in
plastic stents, as well as has the advantages of ﬁxation against
the wall and offers good results (12). The most frequent cause
of blockage of metal stents has been attributed to tumor in-
growth (13), which was in agreement with our results.
However, plastic stents have the advantages of being of low
cost, could be changed or replaced and could be used as a pre-
operative step to improve the patient condition and reduce
hyperbilirubinaemia prior to surgery (14).
Technical success rate in our study was 100% for both plas-
tic and metallic stents insertion. For metallic stent insertion, a
100% technical success rate was achieved in Gordon et al.
(15), and Kaiho et al. (16) studies group, while in Men et al.
(17) study, the success rate was 96% and was 75% in Pinol
Interventional radiology in billiary diseases: A non-surgical therapeutic option 467et al. (18) study. As regard plastic stents, Zhai et al. (19) re-
ported a 100% insertion success rate in all attempted stent
applications.
Clinical success rate was judged by relief of jaundice, pruri-
tis, and fever. The mean total bilirubin for all malignant cases
in our study prior to billiary drainage was 15.4 mg/dl + 6.3.
This has signiﬁcantly decreased to 7 mg/dl + 4.3 after 7 days,
and 3.1 mg/dl + 1.2 after 14 days.
Although the clinical outcome of billiary endoprosthesis
insertion is inﬂuenced by a large number of factors, the overall
technical and clinical success rates, as well as procedure-related
morbidity rate was in the range reported by the others (15–
17,20).
4.2. Benign billiary obstruction (stricture)
Benign billiary strictures constitute 25% of all billiary stric-
tures. The occurrence of benign bile duct stenosis is mostly
associated with prior billiary surgery, pancreatic diseases or
sclerosing cholangitis. Surgical procedures involving the bill-
iary tree, most notably cholecystectomy, are the most common
cause of benign billiary stricture (21), which is in agreement
with our results.
The traditional management of benign stricture is surgical,
by creation of a billiary-enteric anastomosis, but 10–30% of
patients have a recurrence of the stenosis at the anastomotic
site. Repeated billiary restenosis causes chronic billiary stasis
and infection; and this can give rise to secondary billiary cir-
rhosis after several years (22,23).
Percutaneous transhepatic treatment of benign billiary
strictures is a therapeutic procedure that is being increasingly
used; allowing internal billiary drainage in which the obstruct-
ing lesion is traversed to permit antegrad drainage of the bile
into the bowel (24).
In our series, we had access in all patients with benign stric-
tures, and successful dilatation in 6 patients (9.37%) with be-
nign strictures out of the included 9 patients (14.06%) in the
study. Although the technique was not successful in the
remaining 3 patients (4.68%), we did not consider this as a fail-
ure of the technique, as our results were comparable to the
published studies (22,23,25).
4.3. Stone removal
The search for a technique that is capable of achieving the
same results as Dormia basket and endoscopic sphincterotomy
to eliminate bile duct stones, with a lower morbidity rate and
maintaining the sphincter function; has led to the rediscover of
balloon sphincteroplasty in recent years (26).
It is reported that the overall morbidity rate of this tech-
nique is low, with short stay in hospital after the procedure
and high success rate (mean 4 days) (27,28), which was consis-
tent with our results.
Also, Manometric studies have already shown the preserva-
tion of sphincter function in patients who undergo endoscopic
balloon sphincteroplasty (29).
The factors that probably contribute to the low morbidity
rate of this technique is the positioning of a safety catheter
for the external billiary drainage, the systematic administration
of prophylactic antibiotics and pancreatic enzyme secretion
inhibitors such as somatostatin which inhibit pancreatic secre-tions to guard against pancreatitis and provokes a relation of
the sphincter of Oddi (26,28).
Also inspite of the multiplicity of the stones in 5/8 patients
in the current study, only 2 patients (3.12%) had to have more
than one session and were in need for fragmentation of the
large sized stones prior to their expulsion into the duodenum.
4.4. Billiary leak
PTBD has proven to be an important adjunct to the manage-
ment of patients with billiary extravasation, as it is associated
with little morbidity and complete recovery may be expected in
most cases (30).
This was the case in our 3 patients (4.68%) of billiary leak
encountered in the study, as successful sealing of the bile leak
was achieved and there was no need for further surgical proce-
dures. Although this was a limited number of patients, its out-
come was encouraging and coinciding with the work of Cozzi
et al. (31), Zyromski and Lillemoe (32), and Ernst et al. (33);
who reported that percutaneous billiary drainage serves to
decompress the billiary system and divert bile ﬂow from the de-
fect in the bile ducts, and may lead to healing of the ﬁstula
making additional billiary surgery unnecessary.
Post-procedure complications developed in total of 11 pa-
tients (17.18%), an incidence which matches with that of the
published literatures (7,34). No major complications were
experienced or required intensive care admission, and no pro-
cedure-related 30-day mortality was present.5. Conclusion
Improvements in the techniques and facilities of billiary inter-
ventions provide the radiologist with ready access into the bill-
iary system to assist in the multidisciplinary management of
patients with complex diseases of the billiary tract. Palliative
drainage and decompression of the billiary tree in malignant
obstructive jaundice, balloon dilatation of benign billiary stric-
tures, stone removal from the bile ducts, and bile diversion in
bile leaks are the main percutaneous transhepatic billiary inter-
ventional techniques which could be done as an alternative
management to surgical interference in high risk patients, with
low morbidity, favorable outcome, and high clinical success
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